Impairment of the transition from proliferative stage to prehypertrophic stage in chondrogenic differentiation of human induced pluripotent stem cells harboring the causative mutation of achondroplasia in fibroblast growth factor receptor 3
Introduction: Achondroplasia (ACH) is a congenital disease which causes dwarfism and many symptoms resulting from skeletal dysplasia. Because present therapeutic strategies are mainly surgical procedures as symptomatic treatments, development of a radical treatment is desired. Clarification of the A...
Main Authors: | Naohiro Horie, Atsuhiko Hikita, Satoru Nishizawa, Sakura Uto, Tsuyoshi Takato, Kazuto Hoshi |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2017-06-01
|
Series: | Regenerative Therapy |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2352320416300608 |
Similar Items
-
The first European consensus on principles of management for achondroplasia
by: Valerie Cormier-Daire, et al.
Published: (2021-07-01) -
Diagnosis of Achondroplasia at Birth: A Case Report
by: Suzit Bhusal, et al.
Published: (2020-02-01) -
Successful Delivery in a Woman With Achondroplasia: A Case Report
by: Mahbooheh Shirazi, et al.
Published: (2017-10-01) -
COURSE OF PREGNANCY AND CHILDBIRTH OF A WOMAN WITH ACHONDROPLASIA
by: G. M. PERTCEVA, et al.
Published: (2017-06-01) -
The results of the survey among the parents of patients with achondroplasia on the role of vosoritide therapy
by: Dmitry A. Popkov, et al.
Published: (2021-08-01)